by Dan Roberts October 2006 The protein Complement Factor H (CFH) has previously been found to play a role in the development of soft confluent drusen leading to AMD (see “CFH and CFB Proteins May Lead to AMD”). CFH has implicated inflammation as part of the AMD pathogenesis, and now, discovery of a new gene [Read More]
Category: Research and Developments
Abortion Drug Offers Hope for People with Central Serous Chorioretinopathy
(Updated August 18, 2018) An abortion drug known as ru486 is showing potential as a treatment for central serous chorioretinopathy (CSC), a condition which can lead to loss of central vision. The drug, also called mifepristone, blocks the action of progesterone, a hormone necessary to sustain pregnancy. It is also a potent antiglucocorticoid agent. Glucocorticoids [Read More]
Age-related Macular Degeneration Does Not Cause Blindness
A revealing opinion poll sponsored by MD Support shows that a strong majority of people affected by AMD do not think of themselves as blind, and they do not want the term to be used to describe their visual impairment. The pronouncement is well known: “age-related macular degeneration (AMD) is the leading cause of blindness [Read More]
Summary of Research and Developments in Macular Degeneration: 2005-2006
by Dan Roberts This is a compilation of significant research in the field of macular degeneration during the period May 2005 through May 2006, beginning with new findings as presented at the 2006 meeting of the Association for Research in Vision and Ophthalmology (ARVO). Triple therapy found to be effective for wet AMD Triple therapy [Read More]
Summary of Research and Developments in Macular Degeneration: 2005-2006
by Dan Roberts This is a compilation of significant research in the field of macular degeneration during the period May 2005 through May 2006, beginning with new findings as presented at the 2006 meeting of the Association for Research in Vision and Ophthalmology (ARVO). Triple therapy found to be effective for wet AMD Triple therapy [Read More]